Previous findings indicate that DDR1 is upregulated in colorectal cancer, breast cancer, lung cancer, glioma, ovarian cancer and esophageal cancer, and is involved in tumor invasion and metastasis [5–10]. Here, DDR1 is linked to central nervous system cancer.